AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive disorder (diagnosed using SCID-IV)
Number of subjects: 151
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 151
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS)
Number of subjects: 151
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: National Eye Institute-Vision Function Questionnaire (NEI-VFQ)
Number of subjects: 151
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile (SIPV)
Number of subjects: 151
Study 11581068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile-68 (SIP)
Number of subjects: 151
Study 9477041 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (Daflon 500 mg = Dios), 2 tablets/day for 2 months
Number of subjects: 107
Study 9477041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 7888231 — intervention group
Group type: COMPARATOR
Intervention: 160 micrograms rgp160 vaccine
Number of subjects: 56
Study 7888231 — intervention group
Group type: COMPARATOR
Intervention: 640 micrograms rgp160 vaccine
Number of subjects: 56
Study 3345623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (oral)
Number of subjects: 8
Study 3345623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (intravenous)
Number of subjects: 8
Study 3345623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine with cimetidine
Number of subjects: 8
Study 28681057 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR with EV
Number of subjects: 0
Study 28681057 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR with EV+AVS
Number of subjects: 0
Study 28681057 — intervention group
Group type: COMPARATOR
Intervention: Standard FFR
Number of subjects: 0
Study 27647031 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pressure-controlled discography (APCD) before ALIF
Number of subjects: 36
Study 27647031 — intervention group
Group type: COMPARATOR
Intervention: ALIF without APCD
Number of subjects: 36
Study 25604762 — intervention group
Group type: EXPERIMENTAL
Intervention: LLIN curtains and water container covers
Number of subjects: 1225
Study 25604762 — intervention group
Group type: EXPERIMENTAL
Intervention: LLIN water container covers
Number of subjects: 1225
Study 25604762 — intervention group
Group type: COMPARATOR
Intervention: Routine vector control activities (Control)
Number of subjects: 1225
Study 23901664 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training programme (8 weeks, 45-60 minutes)
Number of subjects: 245
Study 23901664 — intervention group
Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 245
Study 21371548 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroretentive tablet (GT)
Number of subjects: 0
Study 21371548 — intervention group
Group type: COMPARATOR
Intervention: Conventional tablet (CT)
Number of subjects: 0
Study 21371548 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of GT with CT
Number of subjects: 0
Study 18321153 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 18321153 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 16741654 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg intravenous thiamine
Number of subjects: 30
Study 16741654 — intervention group
Group type: COMPARATOR
Intervention: No thiamine
Number of subjects: 30
Study 14660990 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 311
Study 14660990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311
Study 11913310 — intervention group
Group type: COMPARATOR
Intervention: Chewing gum containing 5% sodium bicarbonate (0 times daily - control)
Number of subjects: 88
Study 11913310 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (1 time daily)
Number of subjects: 88
Study 11913310 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (2 times daily)
Number of subjects: 88
Study 11913310 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (3 times daily)
Number of subjects: 88
Study 9744587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre and post prandial Duplex colour Doppler sonographic measurement of superior mesenteric artery (SMA) flow after a food challenge (200 ml of Ensure Plus)
Number of subjects: 36
Study 9744587 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic steroids introduced to patients with active Crohn's disease
Number of subjects: 36
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW instantaneous dose rate (6 cGy/min single-dose)
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH instantaneous dose rate (15 cGy/min single-dose)
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose total-body irradiation
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated total-body irradiation
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose LOW
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose HIGH
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated LOW
Number of subjects: 157
Study 8276648 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated HIGH
Number of subjects: 157
Study 8276648 — intervention group
Group type: COMPARATOR
Intervention: Steroid treatment
Number of subjects: 157
Study 2663164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg twice daily for two weeks, then 40 mg twice daily for three months)
Number of subjects: 30
Study 2663164 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa (250 mg twice daily for two weeks, then 500 mg twice daily for three months)
Number of subjects: 30
Study 8774 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic solutions
Number of subjects: 0
Study 8774 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic non-electrolyte solutions
Number of subjects: 0
Study 8774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31752969 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based delivery of barrier, short-acting, and long-acting contraceptives by trained community nurses during postpartum visits.
Number of subjects: 0
Study 31752969 — intervention group
Group type: COMPARATOR
Intervention: Routine care including postpartum contraceptive education and counseling without home-based delivery of contraceptives.
Number of subjects: 0
Study 28190252 — intervention group
Group type: EXPERIMENTAL
Intervention: Local reporting
Number of subjects: 1688
Study 28190252 — intervention group
Group type: COMPARATOR
Intervention: Reviewed frequency
Number of subjects: 1688
Study 28190252 — intervention group
Group type: COMPARATOR
Intervention: Initial central review
Number of subjects: 1688
Study 28190252 — intervention group
Group type: COMPARATOR
Intervention: Online consensus review
Number of subjects: 1688
Study 26852499 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric gaseous cryotherapy in addition to traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage.
Number of subjects: 110
Study 26852499 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage without hyperbaric gaseous cryotherapy).
Number of subjects: 110
Study 26852499 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric gaseous cryotherapy.
Number of subjects: 110
Study 23221121 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF) intervention
Number of subjects: 7899
Study 23221121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PBF)
Number of subjects: 7899
Study 21514932 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA with a stylet
Number of subjects: 101
Study 21514932 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA without a stylet
Number of subjects: 101
Study 18496196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative electrophysiological study
Number of subjects: 27
Study 18496196 — intervention group
Group type: EXPERIMENTAL
Intervention: C5 and C6 nerve roots stimulation
Number of subjects: 27
Study 16921043 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose chemotherapy (HDT)
Number of subjects: 187
Study 16921043 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem high-dose chemotherapy (HDT)
Number of subjects: 187
Study 16921043 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete remission after induction chemotherapy
Number of subjects: 187
Study 16921043 — intervention group
Group type: EXPERIMENTAL
Intervention: Three or more sites of metastases
Number of subjects: 187
Study 15015647 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (HCC)
Number of subjects: 23
Study 15015647 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 mg/kg heparin)
Number of subjects: 23
Study 11110854 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-phytate corn-plus-soy diet
Number of subjects: 23
Study 11110854 — intervention group
Group type: COMPARATOR
Intervention: High phytate diet
Number of subjects: 23
Study 9167099 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (30% daily energy intake) with one fish meal daily (3.6 g omega-3/day)
Number of subjects: 55
Study 9167099 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (55-65% VO2max)
Number of subjects: 55
Study 9167099 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish diet
Number of subjects: 55
Study 9167099 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (30% daily energy intake) without fish
Number of subjects: 55
Study 1350232 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine, 4 mg twice daily
Number of subjects: 12
Study 1350232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1350232 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine
Number of subjects: 12
Study 30874803 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized working memory training (Standard; n=14)
Number of subjects: 27
Study 30874803 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized working memory training plus parental problem-solving skills training (Combined; n=13)
Number of subjects: 27
Study 29989385 — intervention group
Group type: EXPERIMENTAL
Intervention: General positive affect elicited through a writing task in Study 1
Number of subjects: 1943
Study 29989385 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete positive emotions (elevation, humor, hubristic pride) in Study 2
Number of subjects: 1943
Study 29989385 — intervention group
Group type: COMPARATOR
Intervention: Control condition in Study 2
Number of subjects: 1943
Study 27557561 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day)
Number of subjects: 0
Study 27557561 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 24562802 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-obstructive CAD
Number of subjects: 37101
Study 24562802 — intervention group
Group type: COMPARATOR
Intervention: Obstructive CAD
Number of subjects: 37101
Study 23079176 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention participants receiving access to a physical activity-focused website with physical activity self-monitoring and enrollment in a Facebook group (n=67)
Number of subjects: 134
Study 23079176 — intervention group
Group type: COMPARATOR
Intervention: Education‐only controls receiving access to a physical activity‐focused website (n=67)
Number of subjects: 134
Study 21154036 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplements to lower homocysteine
Number of subjects: 234
Study 21154036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruff 2 and 7 Selective Attention Test
Number of subjects: 234
Study 17659078 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver intervention for people with dementia and their families (randomised controlled trial)
Number of subjects: 2000
Study 17659078 — intervention group
Group type: COMPARATOR
Intervention: Cross-sectional comprehensive surveys
Number of subjects: 2000
Study 16159043 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit/feedback with peer-derived benchmarks and continuing medical education
Number of subjects: 85
Study 16159043 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study 12017348 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiduxosin 30 mg
Number of subjects: 36
Study 12017348 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiduxosin 60 mg
Number of subjects: 36
Study 12017348 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiduxosin 90 mg
Number of subjects: 36
Study 12017348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10418841 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary catheterization
Number of subjects: 40
Study 7745048 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic intervention with standardized adhesion scoring system
Number of subjects: 0
Study 7745048 — intervention group
Group type: COMPARATOR
Intervention: Control group with active agent or placebo placed in the peritoneal cavity
Number of subjects: 0
Study 2048514 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/fentanyl
Number of subjects: 50
Study 2048514 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 50
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (Nootropil)
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Piritinol (Encephabol, Enerbol)
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Piriditol
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrophenoxin
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Encephabol
Number of subjects: 315
Study 6799848 — intervention group
Group type: EXPERIMENTAL
Intervention: Other drugs (not specified)
Number of subjects: 315
Study 31109289 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation intervention (N=30)
Number of subjects: 90
Study 31109289 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face home visits (N=30)
Number of subjects: 90
Study 31109289 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=30)
Number of subjects: 90
Study 28274941 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Up model of care intervention
Number of subjects: 266
Study 28274941 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care (Control)
Number of subjects: 266
Study 26469868 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective Automatic Mechanical Peripheral Stimulation (AMPS)
Number of subjects: 11
Study 26469868 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11
Study 26469868 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective AMPS
Number of subjects: 11
Study 24128075 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement intervention with chances to win $1-$100 prizes for meeting walking recommendations
Number of subjects: 45
Study 24128075 — intervention group
Group type: COMPARATOR
Intervention: Control condition with pedometers and guidelines to walk 10,000 steps/day
Number of subjects: 45
Study 21410332 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based intervention providing information on contraceptive methods and modeling desirable future planning behaviors
Number of subjects: 0
Study 21410332 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 19840308 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm Excimer laser treatment, applied twice a week for 12 weeks
Number of subjects: 9
Study 19840308 — intervention group
Group type: COMPARATOR
Intervention: Control patches (not treated with the 308-nm Excimer laser)
Number of subjects: 9
Study 19840308 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm Excimer laser treatment
Number of subjects: 9
Study 18092260 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 18092260 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study 18092260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (standard dosage)
Number of subjects: 0
Study 18092260 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (double dosage)
Number of subjects: 0
Study 15374764 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ergonomic and job stress intervention (ergonomic intervention plus two 1-h workshops on stress management)
Number of subjects: 70
Study 15374764 — intervention group
Group type: COMPARATOR
Intervention: Ergonomics intervention (assessment and modification of work station and stretching exercises)
Number of subjects: 70
Study 11153772 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCR (Percutaneous Transluminal Coronary Revascularization)
Number of subjects: 450
Study 11153772 — intervention group
Group type: COMPARATOR
Intervention: CABG (Coronary Artery Bypass Graft)
Number of subjects: 450
Study 9039239 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 100 mg
Number of subjects: 22
Study 9039239 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 250 mg
Number of subjects: 22
Study 9039239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7892950 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin-thromboxane system assessment in newborns with perinatal hypoxia
Number of subjects: 122
Study 7892950 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic intrauterine hypoxia
Number of subjects: 122
Study 3229870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine 4 mg
Number of subjects: 40
Study 3229870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine 8 mg
Number of subjects: 40
Study 3229870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine 12 mg
Number of subjects: 40
Study 3229870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine 16 mg
Number of subjects: 40
Study 3229870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine 20 mg
Number of subjects: 40
Study 3229870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31538396 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCopilot
Number of subjects: 141
Study 31538396 — intervention group
Group type: COMPARATOR
Intervention: MSFC
Number of subjects: 141
Study 31538396 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCopilot and MSFC correlation
Number of subjects: 141
Study 31538396 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCopilot test-retest
Number of subjects: 141
Study 31027060 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT) for 30 minutes a day, 3 days a week for 4 weeks + conventional physical therapy
Number of subjects: 30
Study 31027060 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy only
Number of subjects: 30
Study 28652725 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium bromide 400 μg BID
Number of subjects: 277
Study 28652725 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 μg QD
Number of subjects: 277
Study 28652725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277
Study 26136410 — intervention group
Group type: EXPERIMENTAL
Intervention: specific medical food for 4 weeks
Number of subjects: 64
Study 26136410 — intervention group
Group type: COMPARATOR
Intervention: routine care control arm (non-caloric placebo or iso-caloric control)
Number of subjects: 64
Study 24157144 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal cocktail periarticular injection with steroid
Number of subjects: 72
Study 24157144 — intervention group
Group type: COMPARATOR
Intervention: Multimodal cocktail periarticular injection without steroid
Number of subjects: 72
Study 24157144 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 21916908 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (counselling on osteoporosis, risk factors, lifestyle modifications, goals of therapy, side effects, and importance of adherence)
Number of subjects: 0
Study 21916908 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 0
Study 21916908 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (counselling)
Number of subjects: 0
Study 19673711 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 6441
Study 19673711 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin plus GPI
Number of subjects: 6441
Study 19673711 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 6441
Study 16509977 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based discussions including exercises that required managing new information
Number of subjects: 0
Study 16509977 — intervention group
Group type: COMPARATOR
Intervention: Standard case discussions without information management exercises (Control)
Number of subjects: 0
Study 16509977 — intervention group
Group type: EXPERIMENTAL
Intervention: Third rotation students
Number of subjects: 0
Study 15703139 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency (HF) PTA over 3, 4 and 6 kHz for adults not exposed to hazardous occupational noise
Number of subjects: 0
Study 11742777 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing-led care with no routine medical intervention (n=89)
Number of subjects: 175
Study 11742777 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care (n=86)
Number of subjects: 175
Study 9407512 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux polysulfone AN69 (HF) hemodialysis
Number of subjects: 25
Study 9407512 — intervention group
Group type: COMPARATOR
Intervention: Low flux (LF) hemodialysis
Number of subjects: 25